These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 27916607)

  • 1. Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy.
    Zhu L; Staley C; Kooby D; El-Rays B; Mao H; Yang L
    Cancer Lett; 2017 Mar; 388():139-148. PubMed ID: 27916607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced iron oxide nanotheranostics for multimodal and precision treatment of pancreatic ductal adenocarcinoma.
    Zhu L; Mao H; Yang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1793. PubMed ID: 35396932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles.
    Satpathy M; Wang L; Zielinski RJ; Qian W; Wang YA; Mohs AM; Kairdolf BA; Ji X; Capala J; Lipowska M; Nie S; Mao H; Yang L
    Theranostics; 2019; 9(3):778-795. PubMed ID: 30809308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF-1 receptor targeted nanoparticles for image-guided therapy of stroma-rich and drug resistant human cancer.
    Zhou H; Qian W; Uckun FM; Zhou Z; Wang L; Wang A; Mao H; Yang L
    Proc SPIE Int Soc Opt Eng; 2016 Apr; 9836():. PubMed ID: 27313332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.
    Gao N; Bozeman EN; Qian W; Wang L; Chen H; Lipowska M; Staley CA; Wang YA; Mao H; Yang L
    Theranostics; 2017; 7(6):1689-1704. PubMed ID: 28529645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostic Nanoparticles for Pancreatic Cancer Treatment.
    Jaidev LR; Chede LS; Kandikattu HK
    Endocr Metab Immune Disord Drug Targets; 2021; 21(2):203-214. PubMed ID: 32416712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances.
    Miller-Kleinhenz JM; Bozeman EN; Yang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(6):797-816. PubMed ID: 25966677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers and pathways of chemoresistance and chemosensitivity for personalized treatment of pancreatic adenocarcinoma.
    Zemanek T; Melichar B; Lovecek M; Soucek P; Mohelnikova-Duchonova B
    Pharmacogenomics; 2019 Jan; 20(2):113-127. PubMed ID: 30539680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theranostics and metabolotheranostics for precision medicine in oncology.
    Bhujwalla ZM; Kakkad S; Chen Z; Jin J; Hapuarachchige S; Artemov D; Penet MF
    J Magn Reson; 2018 Jun; 291():141-151. PubMed ID: 29705040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging biomarkers in oncology: Basics and application to MRI.
    Dregely I; Prezzi D; Kelly-Morland C; Roccia E; Neji R; Goh V
    J Magn Reson Imaging; 2018 Jul; 48(1):13-26. PubMed ID: 29969192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging-guided photothermal/photodynamic therapy against tumor by iRGD-modified indocyanine green nanoparticles.
    Yan F; Wu H; Liu H; Deng Z; Liu H; Duan W; Liu X; Zheng H
    J Control Release; 2016 Feb; 224():217-228. PubMed ID: 26739551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer nanotheranostics: Strategies, promises and impediments.
    Roy Chowdhury M; Schumann C; Bhakta-Guha D; Guha G
    Biomed Pharmacother; 2016 Dec; 84():291-304. PubMed ID: 27665475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.
    Lee GY; Qian WP; Wang L; Wang YA; Staley CA; Satpathy M; Nie S; Mao H; Yang L
    ACS Nano; 2013 Mar; 7(3):2078-89. PubMed ID: 23402593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized Immuno-Oncology.
    Jain KK
    Med Princ Pract; 2021; 30(1):1-16. PubMed ID: 32841942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-based tumor theranostics with molecular imaging.
    Wang L; Wang Y; Li Z
    Curr Pharm Biotechnol; 2013; 14(7):683-92. PubMed ID: 24372235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided Approaches.
    Huang J; Li Y; Orza A; Lu Q; Guo P; Wang L; Yang L; Mao H
    Adv Funct Mater; 2016 Jun; 26(22):3818-3836. PubMed ID: 27790080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is recent in pancreatic cancer immunotherapy?
    Niccolai E; Prisco D; D'Elios MM; Amedei A
    Biomed Res Int; 2013; 2013():492372. PubMed ID: 23509731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy.
    Li Y; Chen Y; Li J; Zhang Z; Huang C; Lian G; Yang K; Chen S; Lin Y; Wang L; Huang K; Zeng L
    Cancer Sci; 2017 Jul; 108(7):1493-1503. PubMed ID: 28444967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.